Nortriptyline Hydrochloride structure
|
Common Name | Nortriptyline Hydrochloride | ||
---|---|---|---|---|
CAS Number | 894-71-3 | Molecular Weight | 299.838 | |
Density | N/A | Boiling Point | 403.4ºC at 760 mmHg | |
Molecular Formula | C19H22ClN | Melting Point | 217-220ºC | |
MSDS | Chinese USA | Flash Point | 194.9ºC | |
Symbol |
GHS07 |
Signal Word | Warning |
Use of Nortriptyline HydrochlorideNortriptyline hydrochloride is a tricyclic antidepressant used to relieve the symptoms of depression. |
Name | Nortriptyline Hydrochloride |
---|---|
Synonym | More Synonyms |
Description | Nortriptyline hydrochloride is a tricyclic antidepressant used to relieve the symptoms of depression. |
---|---|
Related Catalog |
Boiling Point | 403.4ºC at 760 mmHg |
---|---|
Melting Point | 217-220ºC |
Molecular Formula | C19H22ClN |
Molecular Weight | 299.838 |
Flash Point | 194.9ºC |
Exact Mass | 299.144073 |
PSA | 12.03000 |
LogP | 5.01930 |
Appearance of Characters | powder | white to off-white |
Storage condition | 2-8°C |
Water Solubility | ethanol: 100 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn,T,F |
Risk Phrases | R22 |
Safety Phrases | 22-36-45-24-16-7 |
RIDADR | UN 1230 3/PG 2 |
WGK Germany | 3 |
RTECS | HP0175000 |
Kinetic modelling for the assay of nortriptyline hydrochloride using potassium permanganate as oxidant.
AAPS PharmSciTech 16 , 569-78, (2015) Kinetic methods for accurate determination of nortriptyline hydrochloride have been described. The methods are based on the oxidation of nortriptyline hydrochloride with KMnO4 in acidic and basic medi... |
|
Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Biochem. Pharmacol. 95 , 311-23, (2015) Different lines of evidence indicate that the lysophosphatidic acid (LPA) receptor LPA1 is involved in neurogenesis, synaptic plasticity and anxiety-related behavior, but little is known on whether th... |
|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Chem. Res. Toxicol. 23 , 1215-22, (2010) Drug-induced liver injury is a major issue of concern and has led to the withdrawal of a significant number of marketed drugs. An understanding of structure-activity relationships (SARs) of chemicals ... |
1-propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride |
3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-yliden)-N-methylpropan-1-aminhydrochlorid |
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine hydrochloride |
3-(10,11-dihydro-5H-dibenzo[a,d][7]annulén-5-ylidène)-N-méthylpropan-1-amine chlorhydrate |
3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methyl-1-propanamine hydrochloride (1:1) |
pamelor hydrochloride |
1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N-methyl-, hydrochloride (1:1) |
EINECS 212-973-0 |
MFCD00058024 |
3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N-methylpropan-1-amine hydrochloride (1:1) |
N-[3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl]-N-methylamine hydrochloride |
nortriptyline hydrochloride |